Perspectum Diagnostics Ltd

Perspectum Diagnostics Ltd has 2 AI-enabled medical devices on the FDA list. The first decision was on January 9, 2019 and the most recent on June 27, 2019 (LiverMultiScan (LMSv3)). Its most common review panel is Radiology (2 devices).